CIBSS News

Latest news about signalling science and CIBSS scientists

'Blood washing' with light makes cancer immunotherapies much more tolerable.
· News

'Blood washing' with light makes cancer immunotherapies much more tolerable.

A successful clinical study led by CIBSS member Prof. Dr. Robert Zeiser has shown that blood cells exposed to UV light reduce inflammatory reactions controlled by a lipid metabolism molecule.

More
Breaking Barriers: New Seed Money Funding for Plant Cell Wall Permeability Study
· News

Breaking Barriers: New Seed Money Funding for Plant Cell Wall Permeability Study

Eucor - The European Campus is funding four cross-border research projects, including one by CIBSS member Prof. Dr. Laura Ragni on the regulation of hydrophobic biopolymers in plant cells

More
Innovative cancer treatment receives major EU funding
· Press Release

Innovative cancer treatment receives major EU funding

Start-up EMUNO Therapeutics receives €2.5 million EIC Transition Grant

More
Researchers have a better understanding of how our cells dispose of waste while developing ways to control it
· Press Release

Researchers have a better understanding of how our cells dispose of waste while developing ways to control it

A research team from Freiburg and Frankfurt has discovered how cells recognise and internally break down waste. The results are relevant for the development of therapies for diseases such as Alzheimer's.

More
How rare gene variants influence metabolism
· Press Release

How rare gene variants influence metabolism

Study identifies new links between genes and metabolites / Publication in Nature Genetics

More
Better together: State of Baden-Württemberg extends funding on research into bacteria-plant-synergy to enhance crop resilience
· Press Release

Better together: State of Baden-Württemberg extends funding on research into bacteria-plant-synergy to enhance crop resilience

CIBSS member Junior Professor Dr. Sjon Hartman receives continued funding for his research into environmentally friendly agriculture

More
Skin cancer: Mechanism of effect of combination immunotherapy deciphered
· Press Release

Skin cancer: Mechanism of effect of combination immunotherapy deciphered

CIBSS member Prof. Dr. Dr. Bertram Bengsch and his team have found an explanation as to why a long-used combination therapy against malignant melanoma is more effective than the individual active substances. The results offer a therapeutic approach for many types of cancer.

More
Highest German research prize for Freiburg cancer researcher
· People

Highest German research prize for Freiburg cancer researcher

Gottfried Wilhelm Leibniz Prize 2025 goes to CIBSS member Prof. Dr. Robert Zeiser for his outstanding research in haematology and immunology. Zeiser's research has led, among other things, to new cancer therapies that improve patients' chances of survival and quality of life.

More
Great success for the iGEM Freiburg team at the Grand Jamboree in Paris 2024
· News

Great success for the iGEM Freiburg team at the Grand Jamboree in Paris 2024

The Freiburg 2024 team is awarded the prize for the Best Infectious Disease Project at the international competition for synthetic biology. A Report by Liv Neumann.

More
European Union funds research into the adaptability of tissues
· People

European Union funds research into the adaptability of tissues

CIBSS member Dr. Peter Walentek from the Medical Center – University of Freiburg receives an ERC grant of two million euros for his research on how tissues change their function through different cell types and what role this plays in diseases

More

 

 

Header image: © Harald Neumann / University of Freiburg